Importance of Patient Input in Designing CRISPR Trials
Clinical trials of genome editing to treat sickle cell anemia must be designed with input from patients and their parents and physicians, a recent study by National Human Genome Research Institute (NHGRI) scientists concluded.
Source: JAMA - Category: General Medicine Source Type: research